Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Physiology”

1,415 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,415 results

Not applicableLooking for participantsNCT06978777
What this trial is testing

Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity

Who this might be right for
Brown Adipose Tissue (BAT) PhysiologyCold Exposure
University Hospital, Basel, Switzerland 12
Early research (Phase 1)Not Yet RecruitingNCT07248839
What this trial is testing

Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment

Who this might be right for
Healthy VolunteersHepatic Impairment
Bristol-Myers Squibb 24
Not applicableStudy completedNCT01322412
What this trial is testing

Adapted Physical Activity Effect and Fatigue in Patients With Breast Cancer

Who this might be right for
Breast Cancer
University Hospital, Limoges 44
Large-scale testing (Phase 3)Study completedNCT05425719
What this trial is testing

Pharmacokinetics and Safety of MB-102 (Relmapirazin) and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised Subjects

Who this might be right for
Chronic Kidney Disease
MediBeacon 249
Early research (Phase 1)Study completedNCT03521037
What this trial is testing

Rucaparib Hepatic Impairment Study in Patients With a Solid Tumor

Who this might be right for
Neoplasms
pharmaand GmbH 16
Early research (Phase 1)Ended earlyNCT01107899
What this trial is testing

Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes

Who this might be right for
Acute Coronary Syndromes
Eli Lilly and Company 29
Not applicableStudy completedNCT05092932
What this trial is testing

Walking Aid Assessment, Arm Strength and Force Under the Foot in Normal Subjects

Who this might be right for
HealthyPhysical ExaminationMiddle Age+4 more
University of Saskatchewan 40
Early research (Phase 1)Study completedNCT01670734
What this trial is testing

Pharmacokinetic and Tolerability of Alirocumab SAR236553 (REGN727) in Patients With Hepatic Impairment and in Healthy Subjects

Who this might be right for
Hypercholesterolemia
Sanofi 25
Not applicableStudy completedNCT00312832
What this trial is testing

Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral Therapy

Who this might be right for
HIV InfectionsLipoatrophy
Hospital Clinic of Barcelona 60
Early research (Phase 1)Study completedNCT01393964
What this trial is testing

Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 35
Early research (Phase 1)Study completedNCT01299454
What this trial is testing

A Study Evaluating the of OPC-34712 in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 45
Early research (Phase 1)Study completedNCT01443481
What this trial is testing

Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function

Who this might be right for
Solid TumorsHepatic Impairment
Novartis Pharmaceuticals 38
Not applicableNot Yet RecruitingNCT07527819
What this trial is testing

Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)

Who this might be right for
Triple Negative Breast Cancer (TNBC)
Peter MacCallum Cancer Centre, Australia 75
Not applicableLooking for participantsNCT07431567
What this trial is testing

Effect of Acute Hypoxia on RIght VEntRicular Function in Healthy Adults.

Who this might be right for
HypoxiaNormobaric HypoxiaAltitude Hypoxia+1 more
Mona Lichtblau 18
Early research (Phase 1)Study completedNCT03186495
What this trial is testing

Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function

Who this might be right for
Growth Hormone DisorderAdult Growth Hormone DeficiencyGrowth Hormone Deficiency in Children
Novo Nordisk A/S 44
Post-approval studies (Phase 4)Study completedNCT01148667
What this trial is testing

Lactobacillus Rhamnosus GG: Interaction With Human Microbiota and Immunity

Who this might be right for
Gut MicrobiotaSkin MicrobiotaHumoral Immune Responses+1 more
Turku University Hospital 40
Early research (Phase 1)Study completedNCT06485401
What this trial is testing

To Compare the Safety and PK/ PD Characteristics of ADC189 Between Hepatic Impairment and Normal Hepatic Function Subjects

Who this might be right for
Influenza Type AInfluenza Type B
Jiaxing AnDiCon Biotech Co.,Ltd 16
Not applicableStudy completedNCT07127315
What this trial is testing

Assessing Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy

Who this might be right for
Gonadotropin Releasing Hormone AgonistsOvarian FunctionPremenopausal+2 more
Helwan University 100
Early research (Phase 1)Study completedNCT02020434
What this trial is testing

The Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency

Who this might be right for
Subjects With Varying Degrees of Renal Insufficiency andSubjects With Normal Renal Function
Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) 32
Not applicableUnknownNCT04942808
What this trial is testing

The Crestal Bone Loss Around Bone Level Versus Tissue Level Implants in Non-compliant Patients With Healthy or Reduced Periodontium After 5-8 Years in Function

Who this might be right for
PeriimplantitisMarginal Bone Loss
Saint-Joseph University 130
Load More Results